Integrated Filing — IndAS
General information about company
| Scrip Code |
532843 |
| NSE Symbol |
FORTIS |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE061F01013 |
| Name of company |
Fortis Healthcare Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
13-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
06-02-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Third quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
13-02-2026 12:00:00 |
| End date and time of board meeting |
13-02-2026 18:40:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
2,26,501.00 |
6,76,317.00 |
|
Other income |
829.00 |
4,627.00 |
|
Total income |
2,27,330.00 |
6,80,944.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
0.00 |
0.00 |
| (b) |
Purchases of stock-in-trade |
52,223.00 |
1,58,793.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(609.00) |
(1,813.00) |
| (d) |
Employee benefit expense |
32,758.00 |
95,695.00 |
| (e) |
Finance costs |
8,574.00 |
23,019.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
12,014.00 |
32,746.00 |
| (f) |
Other Expenses |
| 1 |
Professional and consultation fees to Doctors |
49,354.00 |
1,44,856.00 |
| 2 |
Other Expenses |
42,210.00 |
1,23,521.00 |
|
Total other expenses |
91,564.00 |
2,68,377.00 |
|
Total expenses |
1,96,524.00 |
5,76,817.00 |
| 3 |
Total profit before exceptional items and tax |
30,806.00 |
1,04,127.00 |
| 4 |
Exceptional items |
(4,591.00) |
(975.00) |
| 5 |
Total profit before tax |
26,215.00 |
1,03,152.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
5,487.00 |
14,283.00 |
| 8 |
Deferred tax |
1,341.00 |
10,582.00 |
| 9 |
Total tax expenses |
6,828.00 |
24,865.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
19,387.00 |
78,287.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
353.00 |
1,013.00 |
| 16 |
Total profit (loss) for period |
19,740.00 |
79,300.00 |
| 17 |
Other comprehensive income net of taxes |
448.00 |
1,029.00 |
| 18 |
Total Comprehensive Income for the period |
20,188.00 |
80,329.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
19,373.00 |
77,593.00 |
|
Total profit or loss, attributable to non-controlling interests |
367.00 |
1,707.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
19,835.00 |
78,637.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
353.00 |
1,692.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
75,496.00 |
75,496.00 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
2.57 |
10.28 |
|
Diluted earnings (loss) per share from continuing operations |
2.57 |
10.28 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
2.57 |
10.28 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
2.57 |
10.28 |
| 24 |
Debt equity ratio |
0.3500 |
0.3500 |
| 25 |
Debt service coverage ratio |
1.7700 |
2.2100 |
| 26 |
Interest service coverage ratio |
6.0400 |
6.9900 |
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| Date of end of reporting
period |
31-12-2025 |
31-12-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Healthcare |
1,93,781.00 |
5,74,946.00 |
| 2 |
Diagnostic |
37,085.00 |
1,13,930.00 |
| 3 |
Inter segment |
0.00 |
0.00 |
|
Total Segment Revenue |
2,30,866.00 |
6,88,876.00 |
|
Less: Inter segment revenue |
4,365.00 |
12,559.00 |
|
Revenue from operations |
2,26,501.00 |
6,76,317.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Healthcare |
33,002.00 |
1,03,895.00 |
| 2 |
Diagnostic |
5,548.00 |
18,624.00 |
| 3 |
Inter segment |
0.00 |
0.00 |
|
Total Profit before tax |
38,550.00 |
1,22,519.00 |
|
i. Finance cost |
8,574.00 |
23,019.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
3,408.00 |
(4,665.00) |
|
Profit before tax |
26,568.00 |
1,04,165.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Healthcare |
11,67,306.00 |
11,67,306.00 |
| 2 |
Diagnostic |
2,11,730.00 |
2,11,730.00 |
| 3 |
Inter segment |
(4,323.00) |
(4,323.00) |
|
Total Segment Asset |
13,74,713.00 |
13,74,713.00 |
|
Un-allocable Assets |
1,69,720.00 |
1,69,720.00 |
|
Net Segment Asset |
15,44,433.00 |
15,44,433.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Healthcare |
1,73,152.00 |
1,73,152.00 |
| 2 |
Diagnostic |
45,197.00 |
45,197.00 |
| 3 |
Inter segment |
(4,323.00) |
(4,323.00) |
|
Total Segment Liabilities |
2,14,026.00 |
2,14,026.00 |
|
Un-allocable Liabilities |
3,40,898.00 |
3,40,898.00 |
|
Net Segment Liabilities |
5,54,924.00 |
5,54,924.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Items that will not be reclassified to profit or loss |
197.00 |
243.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
197.00 |
243.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
45.00 |
38.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Items that will be reclassified to profit or loss |
296.00 |
824.00 |
|
Total Amount of items that will be reclassified to profit and loss |
296.00 |
824.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
448.00 |
1,029.00 |